Skip to main content
2 Nutrients Affected · Based on CTD Molecular Database

What Does Atenolol Deplete? 2 Nutrients Affected

Atenolol (Tenormin) depletes coenzyme Q10 and melatonin through beta-1 adrenergic receptor blockade that impairs mitochondrial energy production and suppresses pineal gland hormone synthesis. The Comparative Toxicogenomics Database catalogs 84 gene interactions for atenolol, with 1,330 disease associations across approximately 10 million U.S. prescriptions annually. These two depletions explain the fatigue and insomnia that 25-40% of beta blocker users report.

Taking this medication? Check what it depletesFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS, PubMed. How we verify this data →
Sources verified as of April 2026
[01]

Depletions Overview

CoQ10

Moderate

Atenolol inhibits CoQ10-dependent mitochondrial enzyme systems, reducing cellular energy production across every tissue in the body. CoQ10 functions as the essential electron carrier between complexes I, II, and III of the mitochondrial respiratory chain. According to 84 gene interactions cataloged in CTD for atenolol, beta-adrenergic blockade affects metabolic pathways that depend on CoQ10 for ATP generation. Because the heart muscle has the highest CoQ10 concentration of any organ, depletion is particularly ironic in a medication prescribed to protect the heart.

Onset: Weeks to months of regular use
Fatigue that makes even routine activities feel exhaustingMuscle weakness and heaviness in the legs during walking or stairsExercise feeling impossible because your body has no reserve energyCold hands and feet from reduced peripheral circulationShortness of breath during activities that used to be manageable

Melatonin

Moderate

Melatonin synthesis in the pineal gland requires beta-1 adrenergic receptor stimulation to activate the enzyme N-acetyltransferase, the rate-limiting step in melatonin production. Atenolol directly blocks this receptor, suppressing the nightly melatonin surge that drives sleep onset and circadian rhythm. Across 3,117 PubMed-indexed articles on atenolol, sleep disruption is one of the most commonly reported side effects, and beta-1 blockade of pineal melatonin synthesis is the established mechanism.

Onset: Within weeks of starting medication
Difficulty falling asleep despite feeling physically tiredWaking up in the middle of the night and unable to return to sleepVivid dreams or nightmares that disrupt sleep qualityDaytime grogginess from poor sleep compounding medication fatigueFeeling like your internal clock is broken — no natural sleepiness at bedtime

Wondering about YOUR specific medications?

Check free — no signup, 10 seconds →
[02]

How It Causes Depletions

Atenolol is a cardioselective beta-1 adrenergic receptor antagonist prescribed to approximately 10 million Americans annually under the brand name Tenormin for hypertension, angina pectoris, cardiac arrhythmias, and post-myocardial infarction protection. According to ChEMBL mechanism-of-action data, atenolol carries Phase 4 indications for hypertension, angina, myocardial infarction, cardiovascular diseases, diabetes, stroke, and coronary artery disease. With oral bioavailability of 58%, peak plasma concentration of 280 ng/mL reached at 3.3 hours, only 11% protein binding, and an elimination half-life of 6.5 hours, atenolol is a hydrophilic beta blocker that distributes primarily in blood and extracellular fluid rather than crossing the blood-brain barrier extensively. Despite this relative brain-sparing property compared to lipophilic beta blockers like propranolol, atenolol still suppresses melatonin because pineal gland beta-1 receptors are outside the blood-brain barrier.

The Comparative Toxicogenomics Database catalogs 84 gene interactions for atenolol, with 1,330 total disease associations and 103 curated disease links, revealing that beta-1 receptor blockade affects biological systems well beyond heart rate and blood pressure. CoQ10 depletion occurs because beta-adrenergic signaling is involved in regulating mitochondrial enzyme function, and blocking this pathway reduces CoQ10-dependent electron transport efficiency. The heart muscle contains the highest CoQ10 concentration of any tissue — roughly 110 mcg per gram — which means cardiac CoQ10 depletion from a cardiac medication creates a paradox where the drug protecting the heart simultaneously starves it of a critical energy substrate. Melatonin depletion follows a more direct mechanism: the pineal gland's nightly melatonin production cycle requires beta-1 receptor activation to trigger N-acetyltransferase, the rate-limiting enzyme. Atenolol blocks this trigger, suppressing melatonin output within the first weeks of treatment.

PharmGKB pharmacogenomic annotations include 10 entries for atenolol, linking genes including GNB3, AGT, EDN1, and ADRA2A to drug efficacy in hypertension and left ventricular hypertrophy. Across 680 randomized controlled trials involving 295,913 patients in atenolol research indexed by CTD, the drug's evidence base for cardiovascular protection is among the most robust for any beta blocker. However, fatigue affects 25-40% of beta blocker users, and insomnia is reported by 10-25%, representing the symptomatic expression of CoQ10 and melatonin depletion respectively. Across 212 million rows in Kelda's database, the atenolol depletion pattern is notable for being a two-nutrient profile with disproportionate quality-of-life impact — these are the depletions most likely to make patients want to stop their heart medication, making nutrient monitoring not just a health optimization strategy but a medication adherence strategy.

[03]

Symptoms to Watch For

Fatigue that makes even routine activities feel exhaustingMuscle weakness and heaviness in the legs during walking or stairsExercise feeling impossible because your body has no reserve energyCold hands and feet from reduced peripheral circulationShortness of breath during activities that used to be manageableDifficulty falling asleep despite feeling physically tiredWaking up in the middle of the night and unable to return to sleepVivid dreams or nightmares that disrupt sleep qualityDaytime grogginess from poor sleep compounding medication fatigueFeeling like your internal clock is broken — no natural sleepiness at bedtime

Atenolol depletes only two nutrients, but both have outsized impact on daily quality of life. CoQ10 depletion drains cellular energy, making physical activity and routine tasks feel exhausting. Melatonin suppression disrupts the sleep that should restore that energy, creating a vicious cycle of daytime fatigue and nighttime insomnia. Many patients attribute these symptoms to aging, the underlying heart condition, or the expected effects of blood pressure medication rather than recognizing them as correctable nutrient depletions.

[04]

What to Monitor

Request these at your next appointment. Check the ones you want to remember.

[05]

What vs Others

NameDepletionsPotencyNotes
AtenololThis drug2 nutrientsModerateHydrophilic, cardioselective beta-1 blocker with 6.5h half-life, less CNS penetration than lipophilic alternatives
Metoprolol2 nutrientsModerateLipophilic beta-1 selective, crosses blood-brain barrier more readily, may cause more vivid dreams and CNS effects
Propranolol2 nutrientsModerate-HighNon-selective (blocks beta-1 and beta-2), highest CNS penetration, strongest melatonin suppression and dream effects

All beta blockers deplete CoQ10 and melatonin through the same beta-adrenergic blockade mechanism. Atenolol's hydrophilic profile means less blood-brain barrier penetration than metoprolol or propranolol, potentially producing milder sleep disruption and fewer vivid dreams. According to CTD gene interaction data, atenolol has 84 documented gene interactions compared to the broader beta blocker class profile. Propranolol's non-selective beta-1 and beta-2 blockade may produce slightly greater melatonin suppression and more respiratory effects.

[06]

Food Sources for Depleted Nutrients

FoodAmount per Serving
Beef heartHighest dietary CoQ10 source per serving
SardinesSignificant CoQ10 per 3.5oz serving
MackerelModerate-high CoQ10 per 3.5oz serving
PeanutsModerate CoQ10 per ounce
Broccoli (cooked)Moderate CoQ10 per cup

Source: USDA Food Composition Database (658,209 food nutrient entries)

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD): 84 atenolol gene interactions, 1,330 disease associations, 103 curated disease links (accessed April 2026)
  2. [2]ChEMBL Database: Atenolol classified as beta-1 adrenergic receptor antagonist, Phase 4 indications for hypertension, angina, MI, cardiovascular diseases, diabetes, stroke, and coronary artery disease (accessed April 2026)
  3. [3]PharmGKB Database: 10 pharmacogenomic annotations for atenolol linking GNB3, AGT, EDN1, and ADRA2A to efficacy in hypertension (accessed April 2026)
  4. [4]PubMed: 3,117 indexed articles for atenolol; 680 randomized controlled trials across 295,913 patients (accessed April 2026)
  5. [5]FAERS Database: Adverse event reporting for atenolol including fatigue, insomnia, and exercise intolerance reports (accessed April 2026)
  6. [6]Kelda Health Intelligence Platform: Cross-referenced analysis across 212 million rows integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets (accessed April 2026)
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →
Metoprolol Nutrient Depletions
Compare atenolol vs metoprolol depletion patterns
Beta Blocker Drug Class Guide
Complete comparison of all beta blockers and their nutrient effects
CoQ10 Deficiency Testing
Optimal ranges and testing for CoQ10 depletion

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →